EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Epigenetic Modulation of IL‐7 and IL‐10: Toward Personalized Immune Therapies in Viral Epidemics

Zerrin Yulugkural iD, Mustafa Yildiz iD, Ertugrul Topcu iD, Habibe Tülin Elmaslar Mert iD, Alp Temiz iD

Journal of Immunology Research · 2026

DOI: 10.1155/jimr/9467657 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Immunology Research, 2026. Verfasst von Zerrin Yulugkural und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases and Clinical Microbiology, Trakya University, Edirne, Türkiye, trakya.edu.tr. Hauptthemen laut MEDLINE: Interleukin-7, Interleukin-10, Epigenesis, Genetic, COVID-19. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Host immune responses, including cytokine production, shape the severity of viral epidemics. Epigenetic mechanisms such as DNA methylation regulate cytokine gene expression and may contribute to immune dysregulation in severe disease.

Methods

This study analyzed interleukin‐7 (IL‐7), IL‐8, and IL‐10 promoter methylation in 145 COVID‐19 patients (91 wards, 54 intensive care units (ICUs)), excluding 12 patients receiving epigenetically active drugs. Peripheral blood DNA underwent bisulfite conversion, followed by PCR and gel electrophoresis. Gene‐specific methylation levels were quantified using beta values.

Results

IL‐7 was significantly hypermethylated overall (β = 0.835, p < 0.001), especially in ICU patients (β = 0.863, p = 0.001), independent of age, mortality, and malignancy. An interaction between age and ICU status indicated group‐specific effects. IL‐10 showed significant hypomethylation (β = 0.243, p < 0.001), while IL‐8 methylation did not differ significantly ( p = 0.373). ICU patients had higher mortality (26% vs 5.5%, p < 0.001).

Conclusion

IL‐7 hypermethylation may impair T‐cell–mediated immunity in severe cases, while IL‐10 hypomethylation may reflect enhanced immunosuppression. These findings suggest a role for epigenetic cytokine regulation in disease progression and may guide future immunomodulatory strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Interleukin-7Interleukin-10Epigenesis, GeneticCOVID-19SARS-CoV-2HumansDNA MethylationFemaleMaleMiddle AgedPromoter Regions, GeneticAdult

Stichwörter der Autor:innen

DNA methylationcytokinesepidemicsepigenesisgeneticimmune response

Substanzen

Interleukin-7Interleukin-10IL10 protein, humanIL7 protein, human

Autor:innen und Institutionen

  • Department of Infectious Diseases and Clinical Microbiology, Trakya University, Edirne, Türkiye, trakya.edu.tr.
  • Department of Biophysics, Trakya University, Edirne, Türkiye, trakya.edu.tr.
  • Department of Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-Universität Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany, fau.eu.
  • Deutsches Zentrum für Immuntherapie (DZI), Friedrich-Alexander-Universität Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany, fau.eu.

ORCID-Profile: Zerrin Yulugkural, Mustafa Yildiz, Ertugrul Topcu, Habibe Tülin Elmaslar Mert, Alp Temiz

Zitieren

APA

Yulugkural, Z., Yildiz, M., Topcu, E., Elmaslar Mert, H. T., & Temiz, A. (2026). Epigenetic Modulation of IL‐7 and IL‐10: Toward Personalized Immune Therapies in Viral Epidemics. Journal of Immunology Research. https://doi.org/10.1155/jimr/9467657

Vancouver

Yulugkural Z, Yildiz M, Topcu E, Elmaslar Mert HT, Temiz A. Epigenetic Modulation of IL‐7 and IL‐10: Toward Personalized Immune Therapies in Viral Epidemics. Journal of Immunology Research. 2026. doi:10.1155/jimr/9467657

BibTeX
@article{Yulugkural2026,
  author = {Yulugkural, Zerrin and Yildiz, Mustafa and Topcu, Ertugrul and Elmaslar Mert, Habibe Tülin and Temiz, Alp},
  title = {Epigenetic Modulation of IL‐7 and IL‐10: Toward Personalized Immune Therapies in Viral Epidemics},
  journal = {Journal of Immunology Research},
  year = {2026},
  doi = {10.1155/jimr/9467657}
}
Kostenlos starten →